Fig. 3 | Scientific Reports

Fig. 3

From: Accurate quantification of cell-free Ceruloplasmin mRNA as a biomarker for early detection of hepatocellular carcinoma

Fig. 3

Comparison of CP mRNA levels between HCC and control groups (chronic liver disease and healthy controls). The box plots depict the median and interquartile ranges of CP mRNA levels in each group, showing significantly higher levels in the HCC group compared to both the chronic liver disease group (p = 0.0066) and the healthy control group (p < 0.0001).

Back to article page